John Radcliffe Hospital
John Radcliffe Hospital
Oxford, United Kingdom15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | Isolated Systolic Hypertension, Systolic Hypertension, cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Recruiting | Not applicable | 2026-10-02 | NCT06059638 | |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-09-16 | NCT02071134 | |
| CHAMPION-AF Clinical Trial | Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-11 | NCT04394546 | |
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, Machado-Joseph disease, Neurologic Manifestations, Spinocerebellar Ataxias, Spinocerebellar Degenerations, atactic disorder, non-human animal, basal ganglia disorder, brain disorder, central nervous system disorder, cerebellar ataxia, cerebellar disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder, spinal cord disorder, spinocerebellar ataxia type 1 | Recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT05822908 | |
| "Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF) | Arrhythmias, Cardiac, Bradycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2026-07-22 | NCT05815745 | |
| On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study | Thrombotic and Bleeding Events | Active, not recruiting | Not stated | 2026-07-14 | NCT02677974 | |
| Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation, persistent atrial fibrillation | Recruiting | Not applicable | 2026-07-13 | NCT07523620 | |
| Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC). | Digestive System Diseases, Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, digestive system disorder, enterocolitis, gastroenteritis, intestinal disorder, necrotizing enterocolitis, pregnancy disorder | Recruiting | Not stated | 2026-03-30 | NCT07192393 | |
| PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Not stated | 2026-03-05 | NCT06923111 | |
| CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia) | Acute Lymphoblastic Leukaemia - Category | Active, not recruiting | Not applicable | 2026-03-05 | NCT04678869 | |
| Early Vasopressors in Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Phase 3 | 2026-02-12 | NCT05179499 | |
| A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease | Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder | Active, not recruiting | Phase 3 | 2026-02-04 | NCT05662241 | |
| A Multi-Arm, Platform Trial For Relapsed Neuroblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-01-12 | NCT07334301 | |
| ACURATE neo2™ Post Market Clinical Follow up Study | Aortic Valve, Calcification of, Ventricular Outflow Obstruction, aortic disorder, aortic valve calcification, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder, vascular disorder | Active, not recruiting | Not stated | 2025-06-25 | NCT04655248 | |
| FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma | Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, myomatous neoplasm, neoplasm, rhabdomyosarcoma, sarcoma | Recruiting | Phase 1 / Phase 2 | 2024-05-23 | NCT04625907 |